France Deep Brain Stimulation Devices Market Size & Outlook
France deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
France deep brain stimulation devices market highlights
- The France deep brain stimulation devices market generated a revenue of USD 33.1 million in 2024 and is expected to reach USD 61.1 million by 2030.
- The France market is expected to grow at a CAGR of 10.9% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 33.1 million |
| Market revenue in 2030 | USD 61.1 million |
| Growth rate | 10.9% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, France accounted for 2.4% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Sweden is the fastest growing regional market in Europe and is projected to reach USD 28.7 million by 2030.
Dystonia was the largest segment with a revenue share of 71.6% in 2024. Horizon Databook has segmented the France deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Mental Health Survey by WHO, France had the highest rate of Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis as of 2017. According to Paris Brain Institute, PD is the second cause of movement disability and affects around 8,000 people every year in France.
Furthermore, according to Fondation de France, one in five people in France is above 60 years, and by the year 2050, the number is expected to be one in three. France is estimated to have the highest incidence of suicide in the European region.
Moreover, growing number of research initiatives and increasing investments for the development of novel procedures involving deep brain stimulation devices is expected to contribute to the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France deep brain stimulation devices market size, by application, 2018-2030 (US$M)
France Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
